Procter & Gamble reported quarterly earnings of $1.88 per share, matching last year’s figure and narrowly beating the consensus estimate by $0.02. Revenue for the period rose 1.5% year-over-year to $22.21 billion, demonstrating resilience in key categories such as Fabric & Home Care and Health Care. Management reiterated full-year guidance of 6.83–7.09 EPS, underscoring confidence in long-term cash generation to support its dividend track record. The board declared a quarterly dividend of $1.0568 per share, translating to an annualized payout of $4.23 and a yield of 2.8%, reflecting a payout ratio of 62.7%.

In its most recent 13F filing, GDS Wealth Management increased its Procter & Gamble position by 20.9%, adding 14,060 shares to reach a total holding of 81,190 shares valued at $12.48 million as of quarter end. Several other asset managers also adjusted their exposures: BAM Wealth Management initiated a stake worth $678,000, Acorn Wealth Advisors added 173 shares to reach 4,028 shares valued at $619,000, and PFG Investments grew its holding by 870 shares to 54,237 shares worth $8.33 million. Overall, institutional ownership stands at 65.8%, highlighting broad professional support for the defensive consumer-goods leader.

Wall Street research remains constructive: fourteen analysts assign a Buy rating and eight a Hold, resulting in a consensus Moderate Buy. Recent target-price revisions include increases to $165 by JPMorgan Chase & Co., to $170 by UBS Group and to $165 by Wells Fargo, while Raymond James adjusted its target down to $175. The average target across the panel stands at $166.70, suggesting upside from current valuation levels and reflecting expectations of mid-single-digit organic sales growth and ongoing margin improvement.